Search results for "Press"

showing 10 items of 15058 documents

Isoprenaline and forskolin increase evoked vasopressin release from rat pituitary

1982

Isolated neurointermediate lobes of rat pituitaries were incubated in Krebs solution. The vasopressin release evoked by electrical stimulation (0.2 ms, 80 V, 15 Hz, 10 s trains at 10 s intervals for a total of 10 min) was completely inhibited by tetrodotoxin. Isoprenaline increased the evoked vasopressin release to a maximum of 60% (EC50 10 nM) and this effect was antagonized surmountably by propranolol. Forskolin increased the vasopressin release by 98%. These results suggest the presence within the neurohypophysis of a beta-adrenoceptor-linked adenylate cyclase facilitating vasopressin secretion.

medicine.medical_specialtyPituitary glandVasopressinVasopressinsStimulationPropranololchemistry.chemical_compoundPituitary Gland PosteriorInternal medicineIsoprenalinemedicineAnimalsPharmacologyForskolinColforsinIsoproterenolRats Inbred StrainsElectric StimulationStimulation ChemicalRatsEndocrinologymedicine.anatomical_structureVasopressin secretionchemistryPituitary GlandTetrodotoxinFemaleDiterpeneshormones hormone substitutes and hormone antagonistsmedicine.drugEuropean Journal of Pharmacology
researchProduct

Escitalopram for the prevention of peginterferon-alpha2a-associated depression in hepatitis C virus-infected patients without previous psychiatric di…

2012

BACKGROUND: Depression is a major complication during treatment of chronic hepatitis C virus (HCV) infection with interferon-alpha (IFN-alpha). It is unclear whether antidepressants can prevent IFN-induced depression in patients without psychiatric risk factors. OBJECTIVE: To examine whether preemptive antidepressant treatment with escitalopram can decrease the incidence or severity of depression associated with pegylated IFN-alpha in HCV-infected patients without a history of psychiatric disorders. DESIGN: Randomized, multicenter, double-blind, prospective, placebo-controlled, parallel-group trial. (ClinicalTrials.gov registration number: NCT00136318) SETTING: 10 university and 11 academic…

medicine.medical_specialtyPlacebolaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicineInternal MedicinemedicineEscitalopram030212 general & internal medicinePsychiatryDepression (differential diagnoses)business.industryIncidence (epidemiology)Absolute risk reductionGeneral MedicineHepatitis Cmedicine.disease3. Good healthTolerability030211 gastroenterology & hepatologybusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologymedicine.drug
researchProduct

Acetyl-L-Carnitine Supplementation and the Treatment of Depressive Symptoms: A Systematic Review and Meta-Analysis.

2017

Objective: Deficiency of acetyl-l-carnitine (ALC) seems to play a role in the risk of developing depression, indicating a dysregulation of fatty acid transport across the inner membrane of mitochondria. However, data about ALC supplementation in humans are limited. We thus conducted a systematic review and meta-analysis investigating the effect of ALC on depressive symptoms across randomized controlled trials (RCTs). Methods: A literature search in major databases, without language restriction, was undertaken from inception until 30 December 2016. Eligible studies were RCTs of ALC alone or in combination with antidepressant medications, with a control group taking placebo/no intervention or…

medicine.medical_specialtyPlacebonot knownlaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicineMedicineHumansAdverse effectApplied PsychologyDepression (differential diagnoses)Randomized Controlled Trials as Topicbusiness.industryDepressionIncidence (epidemiology)Confidence intervalAntidepressive Agents030227 psychiatryPsychiatry and Mental healthMeta-analysisDietary SupplementsVitamin B ComplexAntidepressantbusinessAcetylcarnitine030217 neurology & neurosurgeryPsychosomatic medicine
researchProduct

Is kidney a new organ target in patients with obstructive sleep apnea? Research priorities in a rapidly evolving field.

2021

Abstract The bidirectional relationship between sleep disordered breathing and chronic kidney disease (CKD) has recently gained a lot of interest. Several lines of evidence suggest the high prevalence of coexistent obstructive sleep apnea (OSA) in patients with CKD and end-stage renal disease (ESRD). In addition, OSA seems to result in loss of kidney function in some patients, especially in those with cardio-metabolic comorbidities. Treatment of CKD/ESRD and OSA can alter the natural history of each other; still better phenotyping with selection of appropriate treatment approaches is urgently needed. The aim of this narrative review is to provide an update of recent studies on epidemiologic…

medicine.medical_specialtyPolysomnographyRenal functionDiseasePositive airway pressureSettore MED/10 - Malattie Dell'Apparato Respiratoriourologic and male genital diseasesKidneyEnd stage renal diseaseEnd-stage renal diseaseChronic kidney diseasePositive airway pressureEpidemiologymedicineHumansSleep-disordered breathingIntensive care medicineSleep Apnea Obstructivebusiness.industryResearchGeneral Medicinemedicine.diseaseObstructive sleep apneafemale genital diseases and pregnancy complicationsrespiratory tract diseasesNatural historyObstructive sleep apneaKidney Failure ChronicbusinessKidney diseaseSleep medicine
researchProduct

Perioperative management of obstructive sleep apnea: A systematic review

2018

Introduction Obstructive sleep apnea (OSA) is the leading sleep disordered breathing condition, with a prevalence rate of moderate to severe OSA of approximately 10-17% in the general population. Evidence acquisition We performed an Ovid-Medline search of all articles published up to August 2016. We included all articles providing updated evidence on epidemiology, pathophysiologic mechanisms and perioperative interventions. Evidence synthesis OSA is associated with a number of comorbidities and increased perioperative risks. Although in-laboratory polysomnography represents the gold-standard for diagnosis of OSA, it is costly and time-consuming. Anesthesiologists may screen patients for OSA…

medicine.medical_specialtyPolysomnographymedicine.medical_treatmentPopulation030209 endocrinology & metabolismPolysomnographyPerioperative CarePolysomnography.03 medical and health sciences0302 clinical medicine030202 anesthesiologyObstructive; Perioperative care; Polysomnography.; Sleep apnea; Sleep apnea syndromesmedicineIntubationContinuous positive airway pressureMED/41 - ANESTESIOLOGIAeducationSleep apnea syndromeseducation.field_of_studyPain PostoperativeSleep Apnea Obstructivemedicine.diagnostic_testContinuous Positive Airway Pressurebusiness.industryObstructiveSleep apneaSleep apneaApneaPerioperativemedicine.diseaserespiratory tract diseasesObstructive sleep apneaSleep apnea syndromeAnesthesiology and Pain MedicineEmergency medicinePostoperative Complicationmedicine.symptombusinessHuman
researchProduct

A systematic review of neuropsychiatric symptoms in mild cognitive impairment.

2009

Mild cognitive impairment (MCI) is a clinical concept proposed as an intermediate state between normal aging and dementia. This condition has multiple heterogeneous sources, including clinical presentation, etiology, and prognosis. Recently, the prevalence and associated features of neuropsychiatric symptoms (NPS) in MCI have been described. We systematically searched the PubMed database (last accessed on August 31, 2008) for articles on NPS in MCI. Included articles used strict selection criteria, and outcome variables were extracted in duplicate; of the 27 articles included, 14 (52%) used prospective cohorts. The global prevalence of NPS in MCI ranged from 35% to 85%. The most common beha…

medicine.medical_specialtyPopulationDiseaseNeuropsychological TestsIrritabilitybehavioral disciplines and activitiesAlzheimer DiseaseRisk FactorsInternal medicinemental disordersmedicineDementiaAlzheimer’s disease behavior dementia depression incidence mild cognitive impairment neuropsychiatric symptoms predictors prevalence risk factorsHumansProspective cohort studyeducationDepression (differential diagnoses)education.field_of_studyClinical Trials as TopicGeneral NeuroscienceMental DisordersGeneral Medicinemedicine.diseasePsychiatry and Mental healthClinical PsychologyEtiologyAnxietySettore MED/26 - NeurologiaGeriatrics and Gerontologymedicine.symptomPsychologyCognition DisordersClinical psychologyJournal of Alzheimer's disease : JAD
researchProduct

Patients with Inflammatory Bowel Disease Are Not at Increased Risk of COVID-19: A Large Multinational Cohort Study

2020

The impact of COVID-19 on inflammatory bowel disease (IBD) patients under pharmacological immunosuppression is still not clearly understood. We investigated the incidence of COVID-19 and the impact of immunosuppression and containment measures on the risk of SARS-CoV-2 infection in a large IBD cohort, from a multicenter cohort from 21st of February to 30th of June, 2020. Ninety-seven patients with IBD (43 UC, 53 CD, one unclassified IBD) and concomitant COVID-19 over a total of 23,879 patients with IBD were enrolled in the study. The cumulative incidence of SARS-CoV-2 infection in patients with IBD vs. the general population was 0.406% and 0.402% cases, respectively. Twenty-three patients (…

medicine.medical_specialtyPopulationlcsh:MedicineInflammatory bowel diseaseArticledrugslaw.invention03 medical and health sciences0302 clinical medicinelawinflammatory bowel diseaseInternal medicinemedicineCumulative incidenceeducationeducation.field_of_studyimmunosuppressionbusiness.industryIncidence (epidemiology)lcsh:RCOVID-19General Medicinemedicine.diseaseIntensive care unitdigestive system diseasesPneumonia030220 oncology & carcinogenesisCohort030211 gastroenterology & hepatologybusinessCohort studyJournal of Clinical Medicine
researchProduct

Evaluating depressive symptoms and their impact on outcome in schizophrenia applying the Calgary Depression Scale

2010

Schennach-Wolff R, Obermeier M, Seemuller F, Jager M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkotter J, Heuser I, Maier W, Lemke MR, Ruther E, Klingberg S, Gastpar M, Moller H-J, Riedel M. Evaluating depressive symptoms and their impact on outcome in schizophrenia applying the Calgary Depression Scale. Objective:  To examine depressive symptoms, their course during treatment, and influence on outcome. Method:  Weekly Calgary Depression Scale for Schizophrenia ratings were performed in 249 inpatients with schizophrenia. Early response was defined as a 20% reduction in the total score of the Positive and Negative Syndrome Scale for Schizophrenia from admission to w…

medicine.medical_specialtyPositive and Negative Syndrome ScaleCase-control studyPoison controlmedicine.disease3. Good health030227 psychiatry03 medical and health sciencesPsychiatry and Mental health0302 clinical medicineSchizophreniaInternal medicineInjury preventionmedicinemedicine.symptomPsychiatryPsychologySuicidal ideation030217 neurology & neurosurgeryDepression (differential diagnoses)Cohort studyActa Psychiatrica Scandinavica
researchProduct

Non-invasive ventilation in postoperative patients: A systematic review

2010

Background: Postoperative pulmonary complications, generally defined as any pulmonary abnormality occurring in the postoperative period, are still a significant issue in clinical practice increasing hospital length of stay, morbidity and mortality. Non-invasive ventilation (NIV), primarily applied in cardiogenic pulmonary edema, decompensated COPD and hypoxemic pulmonary failure, is nowadays also used in perioperative settings. Objective: Investigate the application and results of preventive and therapeutic NIV in postsurgical patients. Design: A systematic review. Data sources: Medical literature databases were searched for articles about "clinical trials," "randomized controlled trials" a…

medicine.medical_specialtyPostoperative pneumoniamedicine.medical_treatmentIntensive Care UnitLung injuryAcute respiratory failureCritical Care and Intensive Care MedicinePositive-Pressure RespirationAnesthesiologyIntensive caremedicineHumansContinuous positive airway pressurePostoperative Carebusiness.industryPerioperativeCardiac surgerySurgeryIntensive Care UnitsCardiothoracic surgeryAnesthesiaNon-invasive ventilationAtelectasibusinessAbdominal surgeryHuman
researchProduct

Postural Adaptations in Preadolescent Karate Athletes Due to a One Week Karate Training Camp

2013

Abstract The aim of this study was to investigate the effect of an increasing number of training hours of specific highintensity karate training on postural sway in preadolescent karate athletes. Seventy-four karatekas were randomly assigned to 1 of 2 groups: Karate Group (KG=37): age 10.29±1.68 yrs; or Control Group (CG= 37): age 10.06±1.77 yrs. The KG performed two sessions per day for 1 week in total, while the CG performed only 3 sessions during the same period. The center-of-pressure length (COPL) and velocity (COPV) were recorded under four different experimental conditions: open eyes (EO), closed eyes (EC), open eyes monopodalic left (EOL), open eyes monopodalic right (EOR), pre as w…

medicine.medical_specialtyPostural swayCentre of pressurePhysical Therapy Sports Therapy and RehabilitationPhysical exerciseCentre of pressurePhysiology (medical)Post trainingTraining and testingmedicineKarate trainingtraining and testing; karate training; centre of pressure; proprioception; physical exercise; postural swaybiologyBody balanceAthletesbusiness.industryHigh intensityPhysical exerciseProprioceptionbiology.organism_classificationSettore MED/34 - Medicina Fisica e RiabilitativaSection I – KinesiologyClosed eyesPhysical therapybusinessCentre of pressure; Karate training; Physical exercise; Postural sway; Proprioception; Training and testing; Physical Therapy Sports Therapy and Rehabilitation; Physiology (medical)Research ArticleJournal of Human Kinetics
researchProduct